Breast Cancer: BRCA1 & BRCA2

Mutations involving BRCA1, found on chromosome 17, and BRCA2, found on chromosome 13, increase the risk for specific cancers, such as breast cancer. Discover the last research on breast cancer BRCA1 and BRCA2 here.

January 10, 2021
Open Access

Single-molecule analysis reveals cooperative stimulation of Rad51 filament nucleation and growth by mediator proteins

Molecular Cell
Ondrej BelanSimon J Boulton
January 8, 2021
Open Access

Metaplastic carcinoma of the breast and BRCA1 germline mutation: a case report and review

Hereditary Cancer in Clinical Practice
Michiko YamashitaYasutsugu Takada
January 15, 2021

Prevalence of pathogenic germline variants in patients with metastatic renal cell carcinoma

Genetics in Medicine : Official Journal of the American College of Medical Genetics
María SantosCristina Rodriguez-Antona
January 7, 2021
Open Access

Estimation of Healthcare-related Charges in Women with BRCA Mutations and Breast Cancer

Joseph BiskupiakDavid Stenehjem
January 15, 2021

Integrating PARP inhibitors into the management of breast cancer: where are we?

Chinese Clinical Oncology
Hamdy A AzimHatem Azim
January 14, 2021
Open Access

Estimation of healthcare-related charges in women with BRCA mutations and breast cancer

BMC Health Services Research
Joseph BiskupiakDavid Stenehjem
January 9, 2021
Open Access

Familial pancreatic cancer with PALB2 and NBN pathogenic variants: a case report

Hereditary Cancer in Clinical Practice
Kodai AbeAkira Hirasawa
January 12, 2021
Open Access

Synthetic Lethal Activity of Benzophenanthridine Alkaloids From Zanthoxylum coco Against BRCA1-Deficient Cancer Cells

Frontiers in Pharmacology
Iris A GarcíaGastón Soria
January 13, 2021

High-risk screening using magnetic resonance imaging

Der Radiologe
Ulrich Bick
January 11, 2021

Germline BRCA1/2 mutations and severe haematological toxicities in patients with breast cancer treated with neoadjuvant chemotherapy

European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)
Jenny FurlanettoPeter A Fasching

Sign up to follow this feed and discover related papers.

Related Feeds

Breast Cancer Triple-N

Breast cancer cells have receptors for estrogen, progesterone, HER2 receptors (also called ERBB2). Triple-negative breast cancers do not have any of these receptors. Here are the latest discoveries pertaining to triple-negative breast cancers.

Breast Cancer: Chemo-Resistance

Some cancers are difficult to treat and aggressive including the "triple-negative" breast cancer. This type of cancer is chemoresistant even before chemotherapy begins. Here are the latest discoveries chemo-resistance in breast cancer.

Breast Cancer: Risk Factors

Breast cancer is a multifactorial disease that is influenced by both environmental and genetic factors. Discover the latest research on the environmental and genetic risk factors for breast cancer here.

Breast Cancer: Therapeutic Approaches

Several different therapeutic approaches are used to treat breast cancer. These include chemotherapy, hormonal therapy, targeted therapy, and Immunotherapy. Discover the latest research on breast cancer therapeutic approaches here.

Breast Invasive Carcinoma

Invasive breast cancers indicate a spread into breast tissues and lymph nodes. Here are the latest discoveries pertaining to breast invasive carcinomas.

Breast Tumorigenesis

Breast tumorigenesis involves the production or formation of tumor(s) in breast tissue. Discover the latest research on breast tumorigenesis here.

Carcinoma, Lobular

Lobular carcinoma is an invasive type of breast cancer in which lobules, areas of the breast that produce milk, undergo malignant transformation. Here is the latest research.

Hereditary Breast & Ovarian Cancer

Hereditary breast and ovarian cancer due to mutations in the brca1 and brca2 genes is the most common cause of hereditary forms of both breast and ovarian cancer. Here are the latest discoveries pertaining to these cancers.

Inflammatory Breast Neoplasms

Inflammatory breast cancer is a rare disease characterized by edema and redness of the breast. This is caused by metastatic breast cancer cells blocking lymphatic vessels. Discover the latest research on Inflammatory breast cancer here.

© 2021 Meta ULC. All rights reserved